Symbol | Company | Weighting |
---|---|---|
RNA | AVIDITY BIOSCIENCES INC | 2.61% |
DYN | DYNE THERAPEUTICS, INC. | 2.58% |
AKRO | AKERO THERAPEUTICS INC | 2.26% |
LNTH | LANTHEUS HOLDINGS INC | 2.26% |
IONS | IONIS PHARMACEUTICALS INC | 2.22% |
RYTM | RHYTHM PHARMACEUTICALS INC | 2.06% |
ARGX | ARGENX SE ADR | 2.06% |
ITCI | INTRA-CELLULAR THERAPIES USD | 2.01% |
SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.94% |
DNLI | DENALI THERAPEUTICS INC. | 1.88% |
ALKS | ALKERMES INC | 1.85% |
ISRG | INTUITIVE SURGICAL INC | 1.84% |
NUVL | NUVALENT INC | 1.83% |
ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.82% |
MCK | MCKESSON CORP | 1.81% |
REGN | REGENERON PHARMACEUTICALS | 1.80% |
PCVX | VAXCYTE INC | 1.79% |
ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 1.79% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.75% |
SRPT | SAREPTA THERAPEUTICS INC | 1.74% |
VRTX | VERTEX PHARMACEUTICALS INC | 1.73% |
SNY | SANOFI- AVENTIS- ADR | 1.72% |
RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.72% |
UNH | UNITEDHEALTH GROUP INC | 1.71% |
HCA | HCA HOLDINGS INC | 1.71% |
NBIX | NEUROCRINE BIOSCIENCES INC | 1.69% |
TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.69% |
CRL | CHARLES RIVER LABORATORIES INT INC | 1.68% |
DHR | DANAHER CORP | 1.65% |
AVTR | AVANTOR, INC. | 1.64% |
ZTS | ZOETIS INC | 1.62% |
ACHC | ACADIA HEALTHCARE CO INC | 1.62% |
AMGN | AMGEN CORP | 1.62% |
AZN | ASTRAZENECA PLC-ADR | 1.61% |
SYK | STRYKER CORP | 1.60% |
CYTK | CYTOKINETICS INC | 1.60% |
BSX | BOSTON SCIENTIFIC | 1.59% |
ELV | ELEVANCE HEALTH INC | 1.59% |
BDX | BECTON DICKINSON & CO | 1.58% |
VKTX | VIKING THERAPEUTICS, INC. | 1.56% |
NTRA | NATERA INC | 1.56% |
APLS | APELLIS PHARMACEUTICALS INC | 1.55% |
KURA | KURA ONCOLOGY INC | 1.53% |
NVO | NOVO NORDISK A/S | 1.53% |
IMVT | IMMUNOVANT INC | 1.53% |
MRK | MERCK & CO. NEW | 1.51% |
XNCR | XENCOR INC. | 1.50% |
ARVN | ARVINAS INC USD | 1.46% |
EXAS | EXACT SCIENCES CORP | 1.43% |
IDXX | IDEXX LABS CORP | 1.41% |
BIIB | BIOGEN INC | 1.40% |
TMO | THERMO FISHER SCIENTIFIC INC | 1.40% |
TNDM | TANDEM DIABETES CARE INC | 1.36% |
LLY | ELI LILLY CORP | 1.35% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.29% |
SRRK | SCHOLAR ROCK HLDG CORP USD | 1.19% |
WST | WEST PHARMACEUTICAL SERVICES INC | 1.18% |
EW | EDWARDS LIFESCIENCES CORP | 1.14% |
TARS | TARSUS PHARMACEUTICALS | 1.05% |
DXCM | DEXCOM INC | 0.77% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.